Exact Mass: 476.1512

11a-Hydroxyoxytetracycline

C22H24N2O10 (476.1431)

Temocapril

C23H28N2O5S2 (476.144)

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain Temocapril belongs to the class of organic compounds known as alpha amino acid esters. These are ester derivatives of alpha amino acids. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

Bapta

C22H24N2O10 (476.1431)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].

Erythroxyloside A

C20H28O13 (476.153)

Polygalatenoside D

C20H28O13 (476.153)

SCHEMBL16558850

C27H24O8 (476.1471)

Aspergillusol A

C22H24N2O10 (476.1431)

amygdalinic acid

C20H28O13 (476.153)

(4-Acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranosid)|(4-acetyl-3,5-dihydroxy-phenyl)-(O2-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside)|2,6-dihydroxy-4-(beta-neohesperidosyloxy)acetophenone|4beta-Neohesperidosyl-phloracetophenon|beta-Neohesperidosyl-4-phloracetophenon|Phloroacetophenone 4-O-beta-neohesperidoside|phloroacetophenone 4-neohesperidoside

C20H28O13 (476.153)

arabitol-5-O-(6-O-trans-caffeoyl)-beta-D-glucopyranoside

C20H28O13 (476.153)

5-Methoxy-2-beta-primverosyloxy-benzoesaeure-methylester|5-methoxy-2-beta-primverosyloxy-benzoic acid methyl ester

C20H28O13 (476.153)

4-O-beta-D-apifuranosyl-(1->2)-beta-D-glucopyranosyl-2-hydroxy-6-methoxyacetophenone

C20H28O13 (476.153)

C27H24O8

C27H24O8 (476.1471)

(2R,3R)-6-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]pinobanksin 3-acetate

C27H24O8 (476.1471)

Aegomycin C

C26H30Cl2O4 (476.1521)

(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)-phenylacetic acid|(2R)-(6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranosyloxy)phenylacetic acid|amygdalinic acid|mandelic acid beta-gentiobioside

C20H28O13 (476.153)

(10S)-10-C-(4-O-benzoyl-alpha-arabinopyranosyl)-1,8-dihydroxy-3-methylanthracen-9(10H)-one|picramnioside G

C27H24O8 (476.1471)

Tribenzoyl-alpha-D-Pyranose-2-O-Methylxylose

C27H24O8 (476.1471)

vanillic acid 4-O-neohesperidoside

C20H28O13 (476.153)

PRIMVERIN

C20H28O13 (476.153)

Anti-inflammatory agent 28

C20H28O13 (476.153)

Flunarizine 2HCl

C26H28Cl2F2N2 (476.1597)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Flunarizine dihydrochloride is a potent dual Na+/Ca2+ channel (T-type) blocker. Flunarizine dihydrochloride is a D2 dopamine receptor antagonist. Flunarizine dihydrochloride shows anticonvulsive and antimigraine activity, and peripheral vasodilator effects[1][2][3][4][5].

methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate

C20H28O13 (476.153)

C20H28O13_Benzoic acid, 4-methoxy-2-[(6-O-beta-D-xylopyranosyl-beta-D-glucopyranosyl)oxy]-, methyl ester

C20H28O13 (476.153)

methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based on: CCMSLIB00000848774]

C20H28O13 (476.153)

methyl 4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxybenzoate [IIN-based: Match]

C20H28O13 (476.153)

Cys Glu Glu Pro

C18H28N4O9S (476.1577)

Cys Glu Pro Glu

C18H28N4O9S (476.1577)

Cys His Met Ser

C17H28N6O6S2 (476.1512)

Cys His Ser Met

C17H28N6O6S2 (476.1512)

Cys Met His Ser

C17H28N6O6S2 (476.1512)

Cys Met Ser His

C17H28N6O6S2 (476.1512)

Cys Pro Glu Glu

C18H28N4O9S (476.1577)

Cys Ser His Met

C17H28N6O6S2 (476.1512)

Cys Ser Met His

C17H28N6O6S2 (476.1512)

Asp Asp Met Pro

C18H28N4O9S (476.1577)

Asp Asp Asn Asn

C16H24N6O11 (476.1503)

Asp Asp Pro Met

C18H28N4O9S (476.1577)

Asp Met Asp Pro

C18H28N4O9S (476.1577)

Asp Met Pro Asp

C18H28N4O9S (476.1577)

Asp Asn Asp Asn

C16H24N6O11 (476.1503)

Asp Asn Asn Asp

C16H24N6O11 (476.1503)

Asp Pro Asp Met

C18H28N4O9S (476.1577)

Asp Pro Met Asp

C18H28N4O9S (476.1577)

Glu Cys Glu Pro

C18H28N4O9S (476.1577)

Glu Cys Pro Glu

C18H28N4O9S (476.1577)

Glu Glu Cys Pro

C18H28N4O9S (476.1577)

Glu Glu Pro Cys

C18H28N4O9S (476.1577)

Glu Pro Cys Glu

C18H28N4O9S (476.1577)

Glu Pro Glu Cys

C18H28N4O9S (476.1577)

His Cys Met Ser

C17H28N6O6S2 (476.1512)

His Cys Ser Met

C17H28N6O6S2 (476.1512)

His Met Cys Ser

C17H28N6O6S2 (476.1512)

His Met Ser Cys

C17H28N6O6S2 (476.1512)

His Ser Cys Met

C17H28N6O6S2 (476.1512)

His Ser Met Cys

C17H28N6O6S2 (476.1512)

Met Cys His Ser

C17H28N6O6S2 (476.1512)

Met Cys Ser His

C17H28N6O6S2 (476.1512)

Met Asp Asp Pro

C18H28N4O9S (476.1577)

Met Asp Pro Asp

C18H28N4O9S (476.1577)

Met His Cys Ser

C17H28N6O6S2 (476.1512)

Met His Ser Cys

C17H28N6O6S2 (476.1512)

Met Pro Asp Asp

C18H28N4O9S (476.1577)

Met Ser Cys His

C17H28N6O6S2 (476.1512)

Met Ser His Cys

C17H28N6O6S2 (476.1512)

Asn Asp Asp Asn

C16H24N6O11 (476.1503)

Asn Asp Asn Asp

C16H24N6O11 (476.1503)

Asn Asn Asp Asp

C16H24N6O11 (476.1503)

Pro Cys Glu Glu

C18H28N4O9S (476.1577)

Pro Asp Asp Met

C18H28N4O9S (476.1577)

Pro Asp Met Asp

C18H28N4O9S (476.1577)

Pro Glu Cys Glu

C18H28N4O9S (476.1577)

Pro Glu Glu Cys

C18H28N4O9S (476.1577)

Pro Met Asp Asp

C18H28N4O9S (476.1577)

Ser Cys His Met

C17H28N6O6S2 (476.1512)

Ser Cys Met His

C17H28N6O6S2 (476.1512)

Ser His Cys Met

C17H28N6O6S2 (476.1512)

Ser His Met Cys

C17H28N6O6S2 (476.1512)

Ser Met Cys His

C17H28N6O6S2 (476.1512)

Ser Met His Cys

C17H28N6O6S2 (476.1512)

Primeverin

C20H28O13 (476.153)

iron(iii) chloride hexahydrate

C27H24O8 (476.1471)

barium cyclohexanebutyrate

C20H34BaO4 (476.1509)

Mannopyranose, 6-deoxy-, 2,3,4-tribenzoate

C27H24O8 (476.1471)

2,3,4-Tri-O-benzoyl-L-fucopyranose

C27H24O8 (476.1471)

titanium(iv) cresylate

C28H28O4Ti (476.1467)

Primulaverin

C20H28O13 (476.153)

1,3,5-Tri-O-benzoyl-2-C-methyl-α-D-ribofuranose

C27H24O8 (476.1471)

Feclobuzone

C27H25ClN2O4 (476.1503)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

Methotrexate sodium

C20H21N8NaO5 (476.1533)

D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents

1,3,5-Tri-O-benzoyl-2-O-methyl-D-ribose

C27H24O8 (476.1471)

2,3,5-Tri-O-benzoyl-2-C-methyl-D-ribofuranose

C27H24O8 (476.1471)

2-{5-[3-(7-Propyl-3-trifluoromethylbenzo[D]isoxazol-6-yloxy)propoxy]indol-1-YL}ethanoic acid

C24H23F3N2O5 (476.1559)

N-(Cyclopropylmethyl)-4-(methyloxy)-3-({5-[3-(3-pyridinyl)phenyl]-1,3-oxazol-2-YL}amino)benzenesulfonamide

C25H24N4O4S (476.1518)

(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester

C23H28N2O5S2 (476.144)

Temocapril

C23H28N2O5S2 (476.144)

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

methyl 5-bromo-3-[[2-(4-cyclohexylpiperazin-1-yl)acetyl]amino]-1H-indole-2-carboxylate

C22H29BrN4O3 (476.1423)

Guangsangon L

C27H24O8 (476.1471)

A member of the class of polyphenols consisting of a methylcyclohexene ring attached to a 2,4-dihydroxyphenyl, 2,4-dihydroxybenzoyl and 2,4-dihydroxybenzaldehyde moieties at positions 5, 4 and 3 respectively. Regarded biogenetically as a Diels-Alder adduct, it is isolated from the stem barks of Morus macroura and exhibits antioxidant activity.

N-(2,4-dimethoxyphenyl)-3-[[2-(2-methoxyphenoxy)-1-oxoethyl]amino]-2-benzofurancarboxamide

C26H24N2O7 (476.1583)

methyl 2-[(3-amino-4-carbamoyl-5-cyclohexylimino-2H-thiophene-2-carbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

C22H28N4O4S2 (476.1552)

11a-Hydroxy-oxytetracycline

C22H24N2O10 (476.1431)

(2S,3S,3aR,9bR)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C25H24N4O4S (476.1518)

(2R,3R,3aS,9bS)-1-acetyl-3-(hydroxymethyl)-6-oxo-7-[(E)-2-phenylethenyl]-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C25H24N4O4S (476.1518)

[(3aR,4R,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C27H25FN2O3S (476.157)

[(3aS,4R,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C27H25FN2O3S (476.157)

[(3aS,4S,9bS)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C27H25FN2O3S (476.157)

[(3aR,4S,9bR)-8-[2-(4-fluorophenyl)ethynyl]-1-(4-methylphenyl)sulfonyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C27H25FN2O3S (476.157)

(4S,4aR,5R,5aR,6S,11aS,12aR)-4-(dimethylamino)-1,5,6,10,11a,12a-hexahydroxy-6-methyl-3,11,12-trioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide

C22H24N2O10 (476.1431)

BAPTA

C22H24N2O10 (476.1431)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents BAPTA is a selective chelator for calcium. BAPTA, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA can also inhibit phospholipase C activity independently of their role as Ca2+ chelators[1][2].

5-[6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde

C27H24O8 (476.1471)

(2r,3s)-2,3-dihydroxy-4-{[2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl 2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate

C22H24N2O10 (476.1431)

4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-3-methoxybenzoic acid

C20H28O13 (476.153)

5-[(1s,5r,6r)-6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2,4-dihydroxybenzaldehyde

C27H24O8 (476.1471)

(2R,3 R)-6［1-(4'-hydroxy-3'-methoxyphenyl)prop-2en-1-yl］-pinobanksin-3-acetate

C27H24O8 (476.1471)

{"Ingredient_id": "HBIN006448","Ingredient_name": "(2R,3 R)-6\uff3b1-(4'-hydroxy-3'-methoxyphenyl)prop-2en-1-yl\uff3d-pinobanksin-3-acetate","Alias": "NA","Ingredient_formula": "C27H24O8","Ingredient_Smile": "CC(=O)OC1C(OC2=CC(=C(C(=C2C1=O)O)C(C=C)C3=CC(=C(C=C3)O)OC)O)C4=CC=CC=C4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41730","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

4-hydroxy-2,5-bis(hydroxymethyl)-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate

C20H28O13 (476.153)

4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3-methoxybenzoic acid

C20H28O13 (476.153)

(3r,4s,5s,6r)-6-[(9s)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-4,5-dihydroxyoxan-3-yl benzoate

C27H24O8 (476.1471)

(2r,3s)-2,3-dihydroxy-4-{[(2e)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl (2z)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate

C22H24N2O10 (476.1431)

(1r,2s,5r,6s,14s,17s,18s)-10-{[(2r)-2-carboxy-2-hydroxyethyl]sulfanyl}-17-methyl-9,12-dioxo-15-oxapentacyclo[12.6.0.0¹,⁶.0²,¹⁸.0⁸,¹³]icosa-8(13),10-diene-5-carboxylic acid

C24H28O8S (476.1505)

(r)-phenyl({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid

C20H28O13 (476.153)

2,3-dihydroxy-4-{[2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl 2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate

C22H24N2O10 (476.1431)

1-(4-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone

C20H28O13 (476.153)

(2r,3s)-2,3-dihydroxy-4-{[(2e)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoyl]oxy}butyl (2e)-2-(n-hydroxyimino)-3-(4-hydroxyphenyl)propanoate

C22H24N2O10 (476.1431)

(2s,3s,4r,5r)-4-hydroxy-2,5-bis(hydroxymethyl)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxolan-3-yl 4-methoxybenzoate

C20H28O13 (476.153)

1-(4-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone

C20H28O13 (476.153)

1-(4-{[(2s,3r,4s,5r,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone

C20H28O13 (476.153)

6-(4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl)-4,5-dihydroxyoxan-3-yl benzoate

C27H24O8 (476.1471)

(3r,4s,5s,6r)-6-[(9r)-4,5-dihydroxy-2-methyl-10-oxo-9h-anthracen-9-yl]-4,5-dihydroxyoxan-3-yl benzoate

C27H24O8 (476.1471)

10-[(2-carboxy-2-hydroxyethyl)sulfanyl]-17-methyl-9,12-dioxo-15-oxapentacyclo[12.6.0.0¹,⁶.0²,¹⁸.0⁸,¹³]icosa-8(13),10-diene-5-carboxylic acid

C24H28O8S (476.1505)

phenyl({[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy})acetic acid

C20H28O13 (476.153)

1-(4-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxy-6-methoxyphenyl)ethanone

C20H28O13 (476.153)

methyl 2-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}benzoate

C20H28O13 (476.153)

1-(4-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-2,6-dihydroxyphenyl)ethanone

C20H28O13 (476.153)